Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
09 Avril 2024 - 10:05PM
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics
company, announced today that the company will release its fourth
quarter and full year 2023 financial results on Friday, April 12,
2024, prior to the U.S. market open. The company will host a
conference call and webcast on Friday, April 12, 2024, at 5:00 a.m.
Pacific Time / 8:00 a.m. Eastern Time to discuss its financial
results and highlights.
Interested parties may access the live call via
telephone by dialing toll free (888) 550-5422 for both domestic and
international callers. Once dialed in, ask to be joined to the
Oncocyte Corporation call.
The live webcast of the call may be accessed by
visiting the “Events & Presentations” section of the Company’s
website at https://investors.oncocyte.com. A replay of the
webcast will be available on the Company’s website shortly after
the conclusion of the call.
CONFERENCE CALL
DETAILSParticipant Toll-Free Dial-In Number: (800)
715-9871Participant Toll Dial-In Number: +1 (646)
307-1963Conference ID: 2701195
Webcasthttps://events.q4inc.com/attendee/233145459
About Oncocyte
Oncocyte is a precision diagnostics company. The
Company’s tests are designed to help provide clarity and confidence
to physicians and their patients. VitaGraft™ is a clinical
blood-based solid organ transplantation monitoring test,
GraftAssure™ is a research use only blood-based solid organ
transplantation monitoring test, DetermaIO™ is a gene expression
test that assesses the tumor microenvironment to predict response
to immunotherapies, and the pipeline test DetermaCNI™ is a
blood-based monitoring tool for monitoring therapeutic efficacy in
cancer patients. For more information, visit
https://oncocyte.com/
VitaGraft™, GraftAssure™, DetermaIO™, and
DetermaCNI™ are trademarks of Oncocyte Corporation.
Contact:Jeff RamsonPCG Advisory(646)
863-6893jramson@pcgadvisory.com
Oncocyte (NASDAQ:OCX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Oncocyte (NASDAQ:OCX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024